Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

OBJECTIVES: To examine which composite measures are most sensitive to change when measuring psoriatic arthritis (PsA) disease activity, analyses compared the responsiveness of composite measures used in a 48-week randomized, controlled trial of MTX and etanercept in patients with PsA. METHODS: The t...

Descripción completa

Detalles Bibliográficos
Autores principales: Coates, Laura C, Merola, Joseph F, Mease, Philip J, Ogdie, Alexis, Gladman, Dafna D, Strand, Vibeke, van Mens, Leonieke J J, Liu, Lyrica, Yen, Priscilla K, Collier, David H, Kricorian, Gregory, Chung, James B, Helliwell, Philip S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937022/
https://www.ncbi.nlm.nih.gov/pubmed/32864685
http://dx.doi.org/10.1093/rheumatology/keaa271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937022/
https://www.ncbi.nlm.nih.gov/pubmed/32864685
http://dx.doi.org/10.1093/rheumatology/keaa271

Ejemplares similares